China Universal Asset Management Co. Ltd. Grows Stock Position in Intuitive Surgical, Inc. $ISRG

China Universal Asset Management Co. Ltd. raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 22.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,463 shares of the medical equipment provider’s stock after acquiring an additional 2,102 shares during the quarter. China Universal Asset Management Co. Ltd.’s holdings in Intuitive Surgical were worth $5,127,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently modified their holdings of ISRG. Norges Bank acquired a new position in shares of Intuitive Surgical during the 2nd quarter worth approximately $2,569,260,000. Rakuten Investment Management Inc. acquired a new position in shares of Intuitive Surgical in the third quarter worth $388,436,000. Vanguard Group Inc. raised its holdings in shares of Intuitive Surgical by 2.1% in the second quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock worth $18,115,025,000 after acquiring an additional 670,302 shares during the last quarter. Jennison Associates LLC lifted its position in shares of Intuitive Surgical by 20.4% in the second quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider’s stock valued at $1,696,738,000 after acquiring an additional 528,359 shares in the last quarter. Finally, Bessemer Group Inc. boosted its stake in shares of Intuitive Surgical by 89.3% during the second quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider’s stock valued at $428,386,000 after acquiring an additional 371,806 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In related news, EVP Myriam Curet sold 421 shares of the firm’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $208,378.16. Following the sale, the executive vice president directly owned 409 shares in the company, valued at approximately $202,438.64. This trade represents a 50.72% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, VP Fredrik Widman sold 133 shares of the stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $65,829.68. Following the completion of the sale, the vice president directly owned 660 shares of the company’s stock, valued at $326,673.60. This trade represents a 16.77% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 56,189 shares of company stock worth $30,785,441 in the last ninety days. 0.70% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on ISRG shares. Zacks Research lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Wednesday, January 21st. Sanford C. Bernstein boosted their price target on Intuitive Surgical from $740.00 to $750.00 and gave the company an “outperform” rating in a report on Friday, January 23rd. Barclays set a $712.00 price objective on Intuitive Surgical and gave the stock an “overweight” rating in a report on Monday, January 26th. Rothschild & Co Redburn upped their target price on Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Finally, Wells Fargo & Company increased their target price on Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a research report on Friday, December 12th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $617.23.

Intuitive Surgical Stock Down 0.2%

ISRG opened at $499.53 on Friday. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $608.16. The company has a 50 day moving average of $536.64 and a two-hundred day moving average of $510.37. The company has a market cap of $177.40 billion, a P/E ratio of 63.31, a P/E/G ratio of 3.88 and a beta of 1.65.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. During the same period in the prior year, the company earned $2.21 EPS. The firm’s revenue was up 18.8% on a year-over-year basis. Research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.